Harvard Bioscience Inc HBIO:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/25/22 EDT
3.75quote price arrow down-0.04 (-1.06%)
Volume
143,718
52 week range
3.36 - 8.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.75
  • 52 Week High8.75
  • 52 Week High Date08/13/21
  • 52 Week Low3.36
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap154.65M
  • Shares Out41.24M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.93
  • YTD % Change-46.81

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.75
  • 52 Week High8.75
  • 52 Week High Date08/13/21
  • 52 Week Low3.36
  • 52 Week Low Date05/09/22
  • Market Cap154.65M
  • Shares Out41.24M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.93
  • YTD % Change-46.81

RATIOS/PROFITABILITY

  • EPS (TTM)-0.16
  • P/E (TTM)-23.78
  • Fwd P/E (NTM)12.67
  • EBITDA (TTM)9.066M
  • ROE (TTM)-8.47%
  • Revenue (TTM)120.69M
  • Gross Margin (TTM)56.67%
  • Net Margin (TTM)-5.38%
  • Debt To Equity (MRQ)64.11%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harvard Bioscience Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Harvard Bioscience, Inc. is a developer, manufacturer, and seller of technologies, products and services that enable fundamental research, discovery, and preclinical testing for drug development. The Company provides products that support research in six different classes of laboratory use, including molecular, cellular, tissue, organ, organisms or preclinical, and clinical. The Company organizes its product line activities into two product families, Cellular and Molecular...
James Green
Chairman of the Board, President, Chief Executive Officer
Michael Rossi
Chief Financial Officer
Address
84 OCTOBER HILL RD
Holliston, MA
01746
United States

Top Peers

SYMBOLLASTCHG%CHG
SELB
Selecta Biosciences Inc
0.7063+0.0157+2.27%
DTIL
Precision BioSciences Inc
1.56-0.01-0.64%
CLVS
Clovis Oncology Inc
0.6695+0.0394+6.25%
ATNX
Athenex Inc
0.498-0.0025-0.4995%
PGEN
Precigen Inc
1.24-0.01-0.80%